Kathryn Durham, MD
Dermatology · Fort Worth, TXNPI 1700171196
Payments from drug & device makers
Across 797 payments — averaging $60.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$20K
- E.r. Squibb & Sons, L.L.C.$8K
- AbbVie$4K
- Novartis$2K
- Sanofi$2K
- Lilly USA, LLC$2K
- plus $10K from 29 others
What the payments were for
- Consulting fees$5,07011%
- Speaking & faculty fees$18,60039%
- Travel & lodging$1,4213%
- Food & beverage$22,98948%
- Education$1080%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 63 | $20,181 |
| E.r. Squibb & Sons, L.L.C. | 37 | $7,705 |
| AbbVie(2 entities) | 152 | $3,762 |
| Novartis | 77 | $2,227 |
| Sanofi | 44 | $2,209 |
| Lilly USA, LLC | 48 | $1,826 |
| Amgen | 76 | $1,509 |
| Arcutis Biotherapeutics, Inc. | 32 | $1,163 |
| UCB, Inc. | 18 | $820 |
| LEO Pharma Inc. | 32 | $785 |
| Incyte Corporation | 16 | $748 |
| Regeneron Healthcare Solutions, Inc. | 28 | $702 |
| Johnson & Johnson | 26 | $689 |
| Mayne Pharma Commercial LLC | 41 | $663 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 16 | $549 |
| Sun Pharmaceutical Industries Inc. | 22 | $530 |
| Almirall LLC | 12 | $465 |
| Dermavant Sciences, Inc. | 10 | $324 |
| Janssen Scientific Affairs, LLC | 2 | $198 |
| Bristol Myers Squibb | 16 | $186 |
| Boehringer Ingelheim | 3 | $163 |
| Genentech USA, Inc. | 1 | $121 |
| Biofrontera Inc. | 1 | $117 |
| Kyowa Kirin, Inc. | 2 | $115 |
| Pfizer | 8 | $113 |
| Verrica Pharmaceuticals Inc. | 2 | $95 |
| Aclaris Therapeutics, Inc. | 1 | $46 |
| Revance Therapeutics, Inc. | 2 | $45 |
| DUSA Pharmaceuticals, Inc. | 2 | $33 |
| Botanix SB Inc | 2 | $30 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| VYNE Pharmaceuticals Inc. | 1 | $17 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $14 |
| Journey Medical Corporation | 1 | $13 |
| Organon | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$48,189 in reported general payments places this provider in the 85th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $190,673 |
| Dupixent SyringeDupilumab | 13 | $46,924 |
| Ketoconazole | 280 | $5,680 |
| Triamcinolone Acetonide | 180 | $3,125 |
| Fluocinonide | 85 | $2,770 |
| Tacrolimus | 11 | $1,524 |
| Clobetasol Propionate | 45 | $1,407 |
| Doxycycline Hyclate | 54 | $1,149 |
| Doxycycline Monohydrate | 49 | $942 |
| Clindamycin Phosphate | 28 | $918 |
| ValacyclovirValacyclovir Hcl | 31 | $723 |
| Tretinoin | 11 | $615 |
| Mupirocin | 38 | $295 |
| Spironolactone | 16 | $286 |
| Hydrocortisone | 47 | $246 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fort Worth
- Ronald PlottFort Worth$1.9M
- Patrick KeehanFort Worth$713K
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Craig TellerBellaire$7.7M
- Patricia LeeWebster$7.2M
- Jennifer CatherDallas$4.9M
- Michael MigdenHouston$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.